 | • レポートコード：MRC2-11QY04194 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は小児てんかん治療薬のグローバル市場について調査・分析したレポートです。種類別（良性ローランドてんかん、小児欠神てんかん、若年ミオクロニックてんかん、乳児けいれん、レノックス・ガストー症候群）市場規模、用途別（病院、神経内科センター、在宅医療施設、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別小児てんかん治療薬の競争状況、市場シェア ・世界の小児てんかん治療薬市場：種類別市場規模 2015年-2020年（良性ローランドてんかん、小児欠神てんかん、若年ミオクロニックてんかん、乳児けいれん、レノックス・ガストー症候群） ・世界の小児てんかん治療薬市場：種類別市場規模予測 2021年-2026年（良性ローランドてんかん、小児欠神てんかん、若年ミオクロニックてんかん、乳児けいれん、レノックス・ガストー症候群） ・世界の小児てんかん治療薬市場：用途別市場規模 2015年-2020年（病院、神経内科センター、在宅医療施設、外来手術センター） ・世界の小児てんかん治療薬市場：用途別市場規模予測 2021年-2026年（病院、神経内科センター、在宅医療施設、外来手術センター） ・北米の小児てんかん治療薬市場分析：米国、カナダ ・ヨーロッパの小児てんかん治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの小児てんかん治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の小児てんかん治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの小児てんかん治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、GlaxoSmithKline、Cephalon、Pfizer、Novartis、Sunovion Pharmaceuticals、Bausch Health、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Epilepsy is one of the most common and challenging neurologic disorders affecting children.
Pediatric epilepsies present particular challenges, including correct diagnoses, comorbidities and interactions with developmental processes in the brain.
Market Analysis and Insights: Global Pediatric Epilepsy Therapeutics Market
The global Pediatric Epilepsy Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pediatric Epilepsy Therapeutics Scope and Market Size
Pediatric Epilepsy Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Epilepsy Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
GlaxoSmithKline
Cephalon
Pfizer
Novartis
Sunovion Pharmaceuticals
Bausch Health
Sanofi
Market segment by Type, the product can be split into
Benign Rolandic Epilepsy
Childhood Absence Epilepsy
Juvenile Myoclonic Epilepsy
Infantile Spasms
Lennox-Gastaut Syndrome
Market segment by Application, split into
Hospitals
Neurology Centers
Home Care Settings
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pediatric Epilepsy Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Pediatric Epilepsy Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Benign Rolandic Epilepsy
1.4.3 Childhood Absence Epilepsy
1.4.4 Juvenile Myoclonic Epilepsy
1.4.5 Infantile Spasms
1.4.6 Lennox-Gastaut Syndrome
1.5 Market by Application
1.5.1 Global Pediatric Epilepsy Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Neurology Centers
1.5.4 Home Care Settings
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Epilepsy Therapeutics Market Perspective (2015-2026)
2.2 Global Pediatric Epilepsy Therapeutics Growth Trends by Regions
2.2.1 Pediatric Epilepsy Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pediatric Epilepsy Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Pediatric Epilepsy Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pediatric Epilepsy Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Pediatric Epilepsy Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Epilepsy Therapeutics Players by Market Size
3.1.1 Global Top Pediatric Epilepsy Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Pediatric Epilepsy Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Pediatric Epilepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pediatric Epilepsy Therapeutics Market Concentration Ratio
3.2.1 Global Pediatric Epilepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pediatric Epilepsy Therapeutics Revenue in 2019
3.3 Pediatric Epilepsy Therapeutics Key Players Head office and Area Served
3.4 Key Players Pediatric Epilepsy Therapeutics Product Solution and Service
3.5 Date of Enter into Pediatric Epilepsy Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pediatric Epilepsy Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Pediatric Epilepsy Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020)
5.2 Global Pediatric Epilepsy Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pediatric Epilepsy Therapeutics Market Size (2015-2020)
6.2 Pediatric Epilepsy Therapeutics Key Players in North America (2019-2020)
6.3 North America Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020)
6.4 North America Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pediatric Epilepsy Therapeutics Market Size (2015-2020)
7.2 Pediatric Epilepsy Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020)
7.4 Europe Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Pediatric Epilepsy Therapeutics Market Size (2015-2020)
8.2 Pediatric Epilepsy Therapeutics Key Players in China (2019-2020)
8.3 China Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020)
8.4 China Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pediatric Epilepsy Therapeutics Market Size (2015-2020)
9.2 Pediatric Epilepsy Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020)
9.4 Japan Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pediatric Epilepsy Therapeutics Market Size (2015-2020)
10.2 Pediatric Epilepsy Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Pediatric Epilepsy Therapeutics Market Size (2015-2020)
11.2 Pediatric Epilepsy Therapeutics Key Players in India (2019-2020)
11.3 India Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020)
11.4 India Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pediatric Epilepsy Therapeutics Market Size (2015-2020)
12.2 Pediatric Epilepsy Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Pediatric Epilepsy Therapeutics Introduction
13.1.4 Abbott Laboratories Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Pediatric Epilepsy Therapeutics Introduction
13.2.4 GlaxoSmithKline Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 Cephalon
13.3.1 Cephalon Company Details
13.3.2 Cephalon Business Overview
13.3.3 Cephalon Pediatric Epilepsy Therapeutics Introduction
13.3.4 Cephalon Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020)
13.3.5 Cephalon Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Pediatric Epilepsy Therapeutics Introduction
13.4.4 Pfizer Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Pediatric Epilepsy Therapeutics Introduction
13.5.4 Novartis Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Sunovion Pharmaceuticals
13.6.1 Sunovion Pharmaceuticals Company Details
13.6.2 Sunovion Pharmaceuticals Business Overview
13.6.3 Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Introduction
13.6.4 Sunovion Pharmaceuticals Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020)
13.6.5 Sunovion Pharmaceuticals Recent Development
13.7 Bausch Health
13.7.1 Bausch Health Company Details
13.7.2 Bausch Health Business Overview
13.7.3 Bausch Health Pediatric Epilepsy Therapeutics Introduction
13.7.4 Bausch Health Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020)
13.7.5 Bausch Health Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview
13.8.3 Sanofi Pediatric Epilepsy Therapeutics Introduction
13.8.4 Sanofi Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020)
13.8.5 Sanofi Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pediatric Epilepsy Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Pediatric Epilepsy Therapeutics Revenue
Table 3. Ranking of Global Top Pediatric Epilepsy Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pediatric Epilepsy Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Benign Rolandic Epilepsy
Table 6. Key Players of Childhood Absence Epilepsy
Table 7. Key Players of Juvenile Myoclonic Epilepsy
Table 8. Key Players of Infantile Spasms
Table 9. Key Players of Lennox-Gastaut Syndrome
Table 10. Global Pediatric Epilepsy Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Pediatric Epilepsy Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Pediatric Epilepsy Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Pediatric Epilepsy Therapeutics Market Share by Regions (2015-2020)
Table 14. Global Pediatric Epilepsy Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Pediatric Epilepsy Therapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Pediatric Epilepsy Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Pediatric Epilepsy Therapeutics Players
Table 21. Global Pediatric Epilepsy Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Pediatric Epilepsy Therapeutics Market Share by Players (2015-2020)
Table 23. Global Top Pediatric Epilepsy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Epilepsy Therapeutics as of 2019)
Table 24. Global Pediatric Epilepsy Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Pediatric Epilepsy Therapeutics Product Solution and Service
Table 27. Date of Enter into Pediatric Epilepsy Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Pediatric Epilepsy Therapeutics Market Size Share by Type (2015-2020)
Table 31. Global Pediatric Epilepsy Therapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Pediatric Epilepsy Therapeutics Market Size Share by Application (2015-2020)
Table 33. Global Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Pediatric Epilepsy Therapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Pediatric Epilepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Pediatric Epilepsy Therapeutics Market Share (2019-2020)
Table 37. North America Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Pediatric Epilepsy Therapeutics Market Share by Type (2015-2020)
Table 39. North America Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Pediatric Epilepsy Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Pediatric Epilepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Pediatric Epilepsy Therapeutics Market Share (2019-2020)
Table 43. Europe Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Pediatric Epilepsy Therapeutics Market Share by Type (2015-2020)
Table 45. Europe Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Pediatric Epilepsy Therapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Pediatric Epilepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Pediatric Epilepsy Therapeutics Market Share (2019-2020)
Table 49. China Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Pediatric Epilepsy Therapeutics Market Share by Type (2015-2020)
Table 51. China Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Pediatric Epilepsy Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Pediatric Epilepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Pediatric Epilepsy Therapeutics Market Share (2019-2020)
Table 55. Japan Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Pediatric Epilepsy Therapeutics Market Share by Type (2015-2020)
Table 57. Japan Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Pediatric Epilepsy Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Pediatric Epilepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Pediatric Epilepsy Therapeutics Market Share (2019-2020)
Table 61. Southeast Asia Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Pediatric Epilepsy Therapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Pediatric Epilepsy Therapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Pediatric Epilepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Pediatric Epilepsy Therapeutics Market Share (2019-2020)
Table 67. India Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Pediatric Epilepsy Therapeutics Market Share by Type (2015-2020)
Table 69. India Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Pediatric Epilepsy Therapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Pediatric Epilepsy Therapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Pediatric Epilepsy Therapeutics Market Share (2019-2020)
Table 73. Central & South America Pediatric Epilepsy Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Pediatric Epilepsy Therapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Pediatric Epilepsy Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Pediatric Epilepsy Therapeutics Market Share by Application (2015-2020)
Table 77. Abbott Laboratories Company Details
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Product
Table 80. Abbott Laboratories Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020) (Million US$)
Table 81. Abbott Laboratories Recent Development
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Product
Table 85. GlaxoSmithKline Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020) (Million US$)
Table 86. GlaxoSmithKline Recent Development
Table 87. Cephalon Company Details
Table 88. Cephalon Business Overview
Table 89. Cephalon Product
Table 90. Cephalon Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020) (Million US$)
Table 91. Cephalon Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Product
Table 95. Pfizer Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020) (Million US$)
Table 96. Pfizer Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Product
Table 100. Novartis Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020) (Million US$)
Table 101. Novartis Recent Development
Table 102. Sunovion Pharmaceuticals Company Details
Table 103. Sunovion Pharmaceuticals Business Overview
Table 104. Sunovion Pharmaceuticals Product
Table 105. Sunovion Pharmaceuticals Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020) (Million US$)
Table 106. Sunovion Pharmaceuticals Recent Development
Table 107. Bausch Health Company Details
Table 108. Bausch Health Business Overview
Table 109. Bausch Health Product
Table 110. Bausch Health Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020) (Million US$)
Table 111. Bausch Health Recent Development
Table 112. Sanofi Business Overview
Table 113. Sanofi Product
Table 114. Sanofi Company Details
Table 115. Sanofi Revenue in Pediatric Epilepsy Therapeutics Business (2015-2020) (Million US$)
Table 116. Sanofi Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Epilepsy Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Benign Rolandic Epilepsy Features
Figure 3. Childhood Absence Epilepsy Features
Figure 4. Juvenile Myoclonic Epilepsy Features
Figure 5. Infantile Spasms Features
Figure 6. Lennox-Gastaut Syndrome Features
Figure 7. Global Pediatric Epilepsy Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Neurology Centers Case Studies
Figure 10. Home Care Settings Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Pediatric Epilepsy Therapeutics Report Years Considered
Figure 13. Global Pediatric Epilepsy Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Pediatric Epilepsy Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Pediatric Epilepsy Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Pediatric Epilepsy Therapeutics Market Share by Players in 2019
Figure 18. Global Top Pediatric Epilepsy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Epilepsy Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Pediatric Epilepsy Therapeutics Revenue in 2019
Figure 20. North America Pediatric Epilepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Pediatric Epilepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Pediatric Epilepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Pediatric Epilepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Pediatric Epilepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Pediatric Epilepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Pediatric Epilepsy Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
癲癇診断・治療の世界市場（～2026年） Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the …- 癲癇治療薬の世界市場（～2026年） Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epileps…
- 癲癇治療の世界市場（～2026年） Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epileps…
- 小児神経芽細胞腫治療の世界市場（～2026年） In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017. Market Analysis and Insights: Global Pediatric Neuroblastoma Treatment Market The global Pediatric Neuroblastoma Treatment market size is…
- レノックス・ガストー症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lennox-Gastaut Syndrome Drug Market The global Lennox-Gastaut Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lennox-Gastaut Syndrome Drug Scope and Market Size Lennox…